Australia markets close in 9 minutes

Neumora Therapeutics, Inc. (NMRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.500.00 (0.00%)
At close: 04:00PM EDT
9.49 -0.01 (-0.11%)
After hours: 05:47PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
374,038
240,943
409,247
191,977
Other short-term investments
79,944
130,941
0
-
Total cash
453,982
371,884
409,247
191,977
Total current assets
478,279
387,955
415,603
193,841
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
8,293
11,702
4,639
4,027
Accumulated depreciation
-1,435
-1,060
-598
-105
Net property, plant and equipment
6,858
10,642
4,041
3,922
Equity and other investments
9,845
23,511
0
-
Other long-term assets
1,213
4,126
201
183
Total non-current assets
17,916
38,279
13,694
4,105
Total assets
496,195
426,234
429,297
197,946
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
337
7,147
1,639
2,398
Accrued liabilities
11,246
3,136
12,450
2,081
Other current liabilities
139
1,644
1,487
612
Total current liabilities
25,111
23,697
23,278
9,370
Non-current liabilities
Other long-term liabilities
155
628
386
-
Total non-current liabilities
2,008
849,387
731,240
282,960
Total liabilities
27,119
873,084
754,518
292,330
Stockholders' equity
Common stock
16
3
3
13
Retained earnings
-703,434
-467,509
-336,605
-99,293
Accumulated other comprehensive income
-76
-774
0
-
Total stockholders' equity
469,076
-446,850
-325,221
-94,384
Total liabilities and stockholders' equity
496,195
426,234
429,297
197,946